U.S. flag

An official website of the United States government

NM_022124.6(CDH23):c.8022G>A (p.Gln2674=) AND not specified

Germline classification:
Benign/Likely benign (3 submissions)
Last evaluated:
Oct 20, 2015
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000039279.11

Allele description [Variation Report for NM_022124.6(CDH23):c.8022G>A (p.Gln2674=)]

NM_022124.6(CDH23):c.8022G>A (p.Gln2674=)

Genes:
LOC111982869:Sharpr-MPRA regulatory region 2121 [Gene]
CDH23:cadherin related 23 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q22.1
Genomic location:
Preferred name:
NM_022124.6(CDH23):c.8022G>A (p.Gln2674=)
Other names:
p.Q2674Q:CAG>CAA
HGVS:
  • NC_000010.11:g.71805955G>A
  • NG_008835.1:g.414009G>A
  • NG_056362.1:g.224G>A
  • NM_001171933.1:c.1302G>A
  • NM_001171934.1:c.1302G>A
  • NM_001171936.1:c.-6337G>A
  • NM_022124.6:c.8022G>AMANE SELECT
  • NP_001165404.1:p.Gln434=
  • NP_001165405.1:p.Gln434=
  • NP_071407.4:p.Gln2674=
  • NC_000010.10:g.73565712G>A
  • NM_022124.5:c.8022G>A
  • NP_071407.4:p.(=)
  • c.8022G>A
  • p.Gln2674Gln
Links:
dbSNP: rs201733315
NCBI 1000 Genomes Browser:
rs201733315
Molecular consequence:
  • NM_001171936.1:c.-6337G>A - genic upstream transcript variant - [Sequence Ontology: SO:0002153]
  • NM_001171933.1:c.1302G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001171934.1:c.1302G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_022124.6:c.8022G>A - synonymous variant - [Sequence Ontology: SO:0001819]
Observations:
25

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000062963Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Benign
(May 14, 2012)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000114034Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL Classification Definitions 2015)
Likely benign
(Oct 20, 2015)
germlineclinical testing

Citation Link,

SCV000167625GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Benign
(Jan 28, 2014)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided2525not providednot providednot providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknown3not providednot providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000062963.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided25not providednot providedclinical testing PubMed (1)

Description

Gln2674Gln in Exon 56 of CDH23: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 0.7% (50/6690) of Eu ropean American chromosomes from a broad population by the NHLBI Exome Sequencin g Project (http://evs.gs.washington.edu/EVS).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided25not provided25not provided

From Eurofins Ntd Llc (ga), SCV000114034.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided3not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided3not providednot providednot provided

From GeneDx, SCV000167625.10

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024